Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral nano-silymarin for prevention of vancomycin-induced nephrotoxicity
IRCT20200408046990N9Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in nephrotoxicity, sponsored by Mashhad University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
silymarin
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on IRCT20200408046990N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046990N9.